샘플 요청 목록

 카트 문의
시장보고서
상품코드
1791723

세계의 갱년기 장애 시장

Menopause
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 181 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 갱년기 장애 시장은 2030년까지 223억 달러에 이를 전망

2024년에 173억 달러로 추정되는 갱년기 장애 세계 시장은 분석 기간인 2024-2030년 CAGR 4.3%로 성장하여 2030년에는 223억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 식이보충제는 CAGR 5.0%를 나타내고, 분석 기간 종료시에는 156억 달러에 이를 것으로 예측됩니다. OTC 의약품 부문의 성장률은 분석 기간중 CAGR 2.8%로 추정됩니다.

미국 시장은 47억 달러로 추정, 중국은 CAGR 8.0%로 성장 예측

미국의 갱년기 장애 시장은 2024년에 47억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 46억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 8.0%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.7%와 3.4%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 2.5%를 보일 전망입니다.

세계의 갱년기 장애 케어 시장 - 주요 동향과 시장 성장 촉진요인 정리

갱년기 케어가 헬스케어 업계에서 주목받는 이유는 무엇일까?

여성의 건강, 호르몬 균형, 폐경 후 건강에 대한 인식이 높아지면서 갱년기 케어는 큰 변화의 시기를 맞이하고 있습니다. 갱년기는 생리의 끝을 알리는 생물학적 자연적 전환으로 안면홍조, 식은땀, 기분 저하, 골다공증, 심혈관 위험, 대사 변화 등 다양한 신체적, 정신적 증상을 동반합니다. 전 세계 수백만 명의 여성이 영향을 받고 있음에도 불구하고, 갱년기 치료는 역사적으로 헬스케어 업계에서 논의되지 않았고, 자금도 부족했습니다. 그러나 여성 건강에 대한 인식의 변화, 여성 건강 옹호 운동 증가, 호르몬 요법 및 웰빙 솔루션의 기술 발전으로 갱년기에 초점을 맞춘 치료와 전인적 치료 전략이 붐을 일으키고 있습니다. 제약회사, 디지털 건강 플랫폼, 웰니스 브랜드는 현재 호르몬 대체 요법(HRT), 비호르몬 보충제, 생활습관 개선, AI 기반 폐경 추적 앱 등 폐경 관련 솔루션을 우선순위에 두고 있습니다. 평균 수명의 연장과 적극적인 노화 추세로 인해 더 많은 여성들이 증거에 기반한 갱년기 관리 솔루션을 찾고 있으며, 호르몬 치료 혁신, 원격 건강 상담 갱년기, 개인화된 웰니스 프로그램의 성장에 박차를 가하고 있습니다.

갱년기 치료의 혁신이 증상 관리를 어떻게 개선하고 있는가?

갱년기 케어 시장은 호르몬 요법, 식물 유래 대체의학, 디지털 헬스 솔루션, AI를 활용한 진단의 발전으로 빠르게 진화하고 있습니다. 가장 중요한 개발 중 하나는 생동일성 호르몬과 경피 에스트로겐 패치 등 호르몬 대체 요법(HRT)의 개선입니다. 갱년기 증상에 대한 자연요법을 찾는 여성들을 위해 영양제, 식물성 에스트로겐 기반 보충제, 적응형 허브 등 호르몬 이외의 대체품이 등장하고 있습니다. AI 기반 갱년기 건강 앱, 체온 추적을 위한 웨어러블 기기, 머신러닝 기반 호르몬 분석, 증상 패턴, 생활습관 조정, 치료 권장사항에 대한 실시간 통찰력으로 여성들에게 힘을 실어주고 있습니다. 또한, 원격 건강 플랫폼과 가상 갱년기 클리닉은 여성들이 내분비학자, 산부인과 의사, 영양사와 원격으로 상담할 수 있게 함으로써 전문 진료에 대한 접근성에 혁명을 일으키고 있습니다. 개인 맞춤형 스킨케어, 질 건강 솔루션, 골밀도 유지 보충제 개발도 기존 치료법을 넘어 갱년기 관리를 확장하여 노화 관련 웰니스를 위한 종합적인 생태계를 조성하고 있습니다.

다양한 소비자층에서 갱년기 케어에 대한 수요가 증가하는 이유는 무엇일까?

갱년기 케어 솔루션에 대한 수요는 인식의 향상, 고령화, 갱년기 관련 논의의 비종교화로 인해 전 세계적으로 급증하고 있습니다. 40대, 50대 이후 여성들은 적극적인 건강관리를 우선시하게 되면서 건강보조식품, 웰니스 코칭, 통합적 갱년기 치료의 채택이 증가하고 있습니다. 갱년기 건강에 대한 기업의 웰니스 프로그램이 직장에서 확대되고 있는 것도 시장 성장에 힘을 보태고 있습니다. 고용주는 폐경과 관련된 문제를 겪고 있는 여성 직원을 지원하는 것이 중요하다는 것을 인식하고 있기 때문입니다. 또한, 식물성, 무농약, 전체론적 갱년기 제품에 대한 수요 증가는 클린 라벨 건강 솔루션에 대한 광범위한 추세를 반영합니다. 소셜 미디어, 여성 건강 인플루언서, 갱년기 옹호 단체의 영향력은 여성들에게 가능한 치료 옵션에 대해 더 많은 교육을 제공하고, 금기를 깨고, 중년기 건강과 노화에 대한 공개적인 토론을 장려하고 있습니다.

세계 갱년기 케어 시장의 성장 원동력은?

갱년기 치료 시장의 성장은 헬스케어 투자 증가, 개인 맞춤형 치료에 대한 수요 증가, 호르몬 건강에 대한 AI 기반 진단의 통합으로 인해 발생할 수 있습니다. 디지털 건강 플랫폼, 웨어러블 갱년기 추적기, 원격 건강 상담의 확대로 갱년기 관리가 더욱 접근하기 쉽고 데이터 기반이 되어가고 있습니다. 생동일성 호르몬, 식물성 갱년기 보조제, 장 건강에 초점을 맞춘 치료제가 출시되어 다양한 소비자 취향에 대응하고 있습니다. 호르몬 요법의 안전성에 대한 의학적 연구, 소비자 인식 증가, 갱년기에 초점을 맞춘 웰니스 브랜드의 부상으로 세계 갱년기 케어 시장은 혁신적인 치료법, 디지털 건강의 확대, 홀리스틱 에이징 솔루션에 힘입어 지속적인 성장세를 보일 것으로 전망됩니다. 지속적 성장을 이루고 있습니다.

부문

치료(식이보충제, OTC 의약품)

조사 대상 기업 예

  • Abbott Laboratories
  • AbbVie Inc.
  • Allergan(an AbbVie company)
  • Amneal Pharmaceuticals LLC
  • Avion Pharmaceuticals, LLC
  • Bayer AG
  • Cipla Inc.
  • Duchesnay USA
  • Glenmark Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co.
  • Pfizer Inc.
  • Procter & Gamble Co.
  • Teva Pharmaceutical Industries Ltd.
  • Theramex
  • TherapeuticsMD, Inc.
  • Viatris Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장과 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.21

Global Menopause Market to Reach US$22.3 Billion by 2030

The global market for Menopause estimated at US$17.3 Billion in the year 2024, is expected to reach US$22.3 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Dietary Supplements, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$15.6 Billion by the end of the analysis period. Growth in the OTC Pharma Products segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.7 Billion While China is Forecast to Grow at 8.0% CAGR

The Menopause market in the U.S. is estimated at US$4.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.6 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Menopause Care Market - Key Trends & Growth Drivers Summarized

Why Is Menopause Care Gaining More Attention in the Healthcare Industry?

Menopause care is undergoing a major transformation, as awareness about women’s health, hormonal balance, and post-menopausal wellness reaches new heights. Menopause, a natural biological transition that marks the end of menstruation, is associated with a wide range of physical and emotional symptoms, including hot flashes, night sweats, mood swings, osteoporosis, cardiovascular risks, and metabolic changes. Despite affecting millions of women worldwide, menopause care was historically under-discussed and underfunded in the healthcare industry. However, changing attitudes toward women's health, increased advocacy, and technological advancements in hormone therapy and wellness solutions have led to a boom in menopause-focused treatments and holistic care strategies. Pharmaceutical companies, digital health platforms, and wellness brands are now prioritizing menopause-specific solutions, including hormone replacement therapy (HRT), non-hormonal supplements, lifestyle interventions, and AI-driven menopause tracking apps. With longer life expectancy and proactive aging trends, more women are seeking evidence-based menopause care solutions, fueling growth in hormone therapy innovations, telehealth menopause consultations, and personalized wellness programs.

How Are Innovations in Menopause Care Improving Symptom Management?

The menopause care market is evolving rapidly, thanks to advances in hormone therapy, plant-based alternatives, digital health solutions, and AI-powered diagnostics. One of the most significant developments is the refinement of hormone replacement therapy (HRT), including bioidentical hormones and transdermal estrogen patches, which offer safer, more personalized treatments with reduced side effects. The rise of non-hormonal alternatives, such as nutraceuticals, phytoestrogen-based supplements, and adaptogenic herbs, is catering to women seeking natural remedies for menopause symptoms. AI-driven menopause health apps, wearable devices for temperature tracking, and machine-learning-based hormonal analytics are empowering women with real-time insights into symptom patterns, lifestyle adjustments, and treatment recommendations. Additionally, telehealth platforms and virtual menopause clinics are revolutionizing access to specialized care, allowing women to consult endocrinologists, gynecologists, and nutritionists remotely. The development of personalized skincare, vaginal health solutions, and bone density preservation supplements is also expanding menopause care beyond traditional treatment methods, creating a comprehensive ecosystem for aging-related wellness.

Why Is Demand for Menopause Care Increasing Across Diverse Consumer Segments?

The demand for menopause care solutions is surging globally, driven by increased awareness, aging populations, and the destigmatization of menopause discussions. Women in their 40s, 50s, and beyond are now prioritizing proactive health management, leading to increased adoption of supplements, wellness coaching, and integrative menopause treatments. The expansion of corporate wellness programs addressing menopausal health in the workplace is also fueling market growth, as employers recognize the importance of supporting female employees experiencing menopause-related challenges. Additionally, the rising demand for plant-based, cruelty-free, and holistic menopause products reflects a broader trend toward clean-label health solutions. The influence of social media, women’s health influencers, and menopause advocacy groups is further educating women about available treatment options, breaking taboos, and encouraging open discussions about midlife health and aging.

What Is Driving the Growth of the Global Menopause Care Market?

The growth in the menopause care market is driven by rising healthcare investments, increasing demand for personalized treatments, and the integration of AI-driven diagnostics in hormonal health. The expansion of digital health platforms, wearable menopause trackers, and telehealth consultations is making menopause management more accessible and data-driven. The increasing availability of bioidentical hormones, plant-based menopause supplements, and gut-health-focused treatments is catering to diverse consumer preferences. With greater medical research on hormone therapy safety, growing consumer awareness, and the rise of menopause-focused wellness brands, the global menopause care market is positioned for sustained growth, supported by innovative therapies, digital health expansion, and holistic aging solutions.

SCOPE OF STUDY:

The report analyzes the Menopause market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Dietary Supplements, OTC Pharma Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • AbbVie Inc.
  • Allergan (an AbbVie company)
  • Amneal Pharmaceuticals LLC
  • Avion Pharmaceuticals, LLC
  • Bayer AG
  • Cipla Inc.
  • Duchesnay USA
  • Glenmark Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co.
  • Pfizer Inc.
  • Procter & Gamble Co.
  • Teva Pharmaceutical Industries Ltd.
  • Theramex
  • TherapeuticsMD, Inc.
  • Viatris Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Menopause - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness and Openness Around Menopause Health Throws the Spotlight on Women's Midlife Wellness Market
    • Shifting Demographics and Aging Population Spur Demand for Menopause-Focused Therapies and Products
    • Growing Popularity of Holistic and Natural Remedies Strengthens Business Case for Botanical-Based Menopause Solutions
    • Surge in Femtech Innovations Drives Adoption of Digital Menopause Management Tools
    • Increasing Focus on Personalized Healthcare Expands Addressable Market Opportunity for Customized Menopause Treatments
    • Celebrity and Influencer Advocacy Accelerates Demand for Menopause-Friendly Lifestyle Products
    • Integration of AI in Hormonal Health Diagnostics Drives Precision in Menopause Care Solutions
    • Changing Workplace Policies on Women's Health Drives Inclusion of Menopause Benefits in Corporate Wellness Programs
    • Regulatory Push for Recognition of Menopause as a Health Priority Strengthens Funding and Research Opportunities
    • Rapid Proliferation of Direct-to-Consumer (DTC) Brands Spurs Growth of E-commerce Channels for Menopause Products
    • Emerging Clinical Evidence Around Non-Hormonal Alternatives Propels Market for Non-HRT (Hormone Replacement Therapy) Solutions
    • Heightened Investment Activity in Women's Health Tech Ecosystem Expands Innovation Pipeline for Menopause Startups
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Menopause Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dietary Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for OTC Pharma Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for OTC Pharma Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for OTC Pharma Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • JAPAN
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • CHINA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • EUROPE
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Menopause by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Menopause by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • FRANCE
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • GERMANY
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Spain 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Russia 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Menopause by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Menopause by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Australia 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • INDIA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: India 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: South Korea 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Menopause by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Menopause by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Latin America 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Argentina 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Brazil 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Mexico 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Menopause by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Menopause by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Middle East 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Iran 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Israel 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UAE 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • AFRICA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Africa 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제